Functional Proteins Shift Focus to Digestibility, Rheology, and Clear RTDs

London, United Kingdom — 23 October 2026

Protein ingredient specialists are moving R&D budgets beyond basic nitrogen content. As consumer awareness expands past gross protein numbers on front-of-pack labels, manufacturers are engineering raw materials for specific rheological properties, amino acid completeness, and finished-product sensory stability.

Technical trade-offs have historically restricted high-inclusion formulations. Elevating protein content typically drives up viscosity, produces grittiness, or introduces astringent off-notes. To counter this, Arla Foods Ingredients has diversified its whey isolate architecture. Its Lacprodan line now supports soft-textured performance bars containing up to 37% protein, alongside clear, acidified sports drinks that combine whey isolates with creatine, electrolytes, or collagen. Arla has also developed an ambient-stable, water-based companion shot using Lacprodan BLG-100. Calibrated for consumers on GLP-1 receptor agonists experiencing suppressed appetite, the format packs 21g of protein into a 100ml volume without sugar, fat, or excessive viscosity.

In alternative proteins, processors are diverging between high-functionality isolates and deliberately inert carriers. Leaft Foods is commercialising isolated Rubisco (ribulose-1,5-bisphosphate carboxylase-oxygenase), a leaf-derived complete protein with foaming, gelling, and emulsifying capacity. Leaft has engineered a clear-soluble grade specifically for fruit juices, targeting retail shelves in early 2027. Conversely, Lallemand Bio-Ingredients is targeting everyday food fortification with Engevita HiPro Beyond, an inactive Saccharomyces cerevisiae baker’s yeast protein containing a minimum of 80% protein. The ingredient is intentionally non-functional: it neither gels, foams, nor emulsifies, allowing formulators to enrich soups, baked items, and hybrid dairy matrices like panna cotta without compromising native textures.

What this means for United Kingdom

UK contract manufacturers must prepare for margin migration away from commoditised whey concentrates toward tailored fractions engineered for clear RTDs and compact shots. Regulatory teams must track the novel food compliance status of emerging inputs; while dairy isolates face standard UK Food Standards Agency (FSA) compliance, novel plant extracts such as leaf-derived Rubisco require validated FSA novel food dossiers before distribution in Great Britain. Commercially, high-street retail buyers across Boots and Holland & Barrett are reallocating shelf space toward GLP-1 support and hydration-plus-protein formats. Brands that reformulate bulky 500ml shakes into functional 100ml micro-shots will capture premium per-millilitre pricing.

This trend is being actively addressed by UK manufacturing partners including Supplement Factory.